TY  - JOUR
T1  - REconsideration of igm-enriched intravenous immunoglobulin for neonatal sepsis
AU  - HALL SL
Y1  - 1989/07/01
N1  - 10.1001/archpedi.1989.02150190016008
JO  - American Journal of Diseases of Children
SP  - 766
EP  - 766
VL  - 143
IS  - 7
N2  - To the Editor.—In the article by Haque et al1 in the December 1988 issue of AJDC, the authors concluded that mortality from neonatal sepsis (suspected or proved) was significantly reduced in a group of 30 infants treated in a prospective, randomized trial with IgM-enriched intravenous immunoglobulin (Pentaglobin, Biotest Pharma, Frankfurt, West Germany) in addition to antibiotics compared with a control group of 30 infants who were treated with antibiotics alone.Their conclusion of a statistically significant (P<.001) reduction in mortality between the treated and control groups was based on the use of Student's t test for statistical analysis. Is there some rationale that makes use of the Student t test the appropriate test for analysis of these outcome data?As outcome is a discrete and not a continuous or numerical parameter, a t test, which is a parametric test of the difference in means between two samples
SN  - 0002-922X
M3  - doi: 10.1001/archpedi.1989.02150190016008
UR  - http://dx.doi.org/10.1001/archpedi.1989.02150190016008
ER  -